Healthcare newsletter
Biotech Blueprint: review of price, cadence & strategy
A weekly Friday briefing on biotech: trial readouts, FDA decisions and M&A.
Biotech Blueprint, by Katerina Roznik, PhD, is a weekly analysis of the biotech industry: clinical trial readouts, FDA decisions, M&A and the science behind the headlines. Its Friday briefing, This Week in Biotech, covers industry news, market updates, trial progress and regulatory policy, with short video recaps; deep dives run as podcast episodes. Prices are the publication's web subscription prices on Substack.
Want to see what you get before paying? Read recent issues in the official archive.
Facts checked on 2026-10-27 at the official page. Prices can change; confirm before you subscribe. We do not publish ratings or performance claims.
Similar newsletters
Prosperity Investor (Stansberry Research)
A monthly advisory on investing in health care and medical technology.
Back of the Napkin Bios
Long-only biotech and life-science stock ideas, each posted with a stated buy range.
Double Blind Bets
Early-stage biotech explained for investors, beyond management pitches.